Huimei Zhou

ORCID: 0009-0008-5085-6110 · 9 papers in corpus
observational 2025
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-025-06369-6

OBJECTIVE: To evaluate various body fat indicators under weight management on the time to complete response (CR) in overweight patients undergoing fertility-sparing treatment for endometrial cancer (EC) or atypical hyperplasia (AEH). METHOD…

other 2025
Scientific reports ·doi:10.1038/s41598-025-89270-z

Ovarian clear cell carcinoma (OCCC) is resistant to chemotherapy, with limited treatment options for advanced and recurrent disease. The prevalence of OCCC differs by region. Assessing the expression of programmed cell death ligand 1 (PD-L1…

other 2023
BMC women's health ·doi:10.1186/s12905-023-02420-1

OBJECTIVE: Ovarian clear cell carcinoma (OCCC) is a distinct entity from epithelial ovarian cancer. The prognosis of advanced and recurrent disease is very poor due to resistance to chemotherapeutic agents. Our aim was to explore the molecu…

other 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.812346

OBJECTIVE: To evaluate the efficacy and prognosis of fertility-sparing treatment on endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) patients with BMI ≥ 30 kg/m2. METHODS: A total of 102 EC or AEH patients with obesity wh…

meta-analysis 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.811638

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is an uncommon subtype of epithelial ovarian carcinoma (EOC) that is often diagnosed at an earlier stage in younger women. It remains uncertain whether adjuvant chemotherapy improves the progn…

observational 2022
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003882

OBJECTIVE: To evaluate the efficacy and safety of gonadotropin-releasing hormone agonist (GnRHa) combined with a levonorgestrel-releasing intrauterine device (LNG-IUD) or aromatase inhibitor (letrozole) in women with endometrial carcinoma o…

observational 2021
Frontiers in oncology ·doi:10.3389/fonc.2021.738370

OBJECTIVE: To evaluate the efficacy and prognosis of fertility-sparing re-treatment on patients with recurrent endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) who wish to preserve their uterus after complete remission (CR…

other 2009
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2009.01.022

OBJECTIVE: To analyze the clinical presentation of perineal endometriosis and evaluate its treatment. METHODS: Clinical data were analyzed from the records of 36 patients with perineal endometriosis who were operated on between 1983 and 20…

observational 2008
Chinese medical journal ·doi:10.1097/00029330-200805020-00012

BACKGROUND: Annexin-1 was identified as an endometriosis-related protein by comparative proteomics in previous study. As an endogenous anti-inflammatory mediator, Annexin-1 has been shown to regulate the immune response, cell proliferation …